OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Single-cell CAR T atlas reveals type 2 function in 8-year leukaemia remission
Zhiliang Bai, Bing Feng, Susan McClory, et al.
Nature (2024) Vol. 634, Iss. 8034, pp. 702-711
Open Access | Times Cited: 20
Zhiliang Bai, Bing Feng, Susan McClory, et al.
Nature (2024) Vol. 634, Iss. 8034, pp. 702-711
Open Access | Times Cited: 20
Showing 20 citing articles:
Reinventing type 2 immunity in cancer
Marek Wagner, Hiroyoshi Nishikawa, Shigeo Koyasu
Nature (2025) Vol. 637, Iss. 8045, pp. 296-303
Closed Access | Times Cited: 3
Marek Wagner, Hiroyoshi Nishikawa, Shigeo Koyasu
Nature (2025) Vol. 637, Iss. 8045, pp. 296-303
Closed Access | Times Cited: 3
CAR-T therapy in solid tumors
Bing Du, Juliang Qin, Boxu Lin, et al.
Cancer Cell (2025) Vol. 43, Iss. 4, pp. 665-679
Closed Access | Times Cited: 1
Bing Du, Juliang Qin, Boxu Lin, et al.
Cancer Cell (2025) Vol. 43, Iss. 4, pp. 665-679
Closed Access | Times Cited: 1
Comparative analysis and process optimization for manufacturing CAR-T using the PiggyBac system derived from cryopreserved versus fresh PBMCs
Zenghui Xu, Ruyue Wang, Yuanjian Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Zenghui Xu, Ruyue Wang, Yuanjian Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Targeting γc family cytokines with biologics: current status and future prospects
Fabian Bick, Christophe Blanchetot, Bart N. Lambrecht, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
Fabian Bick, Christophe Blanchetot, Bart N. Lambrecht, et al.
mAbs (2025) Vol. 17, Iss. 1
Open Access
Multiomics with Evolutionary Computation to Identify Molecular and Module Biomarkers for Early Diagnosis and Treatment of Complex Disease
Han Cheng, Mengyu Liang, Yiwen Gao, et al.
Genes (2025) Vol. 16, Iss. 3, pp. 244-244
Open Access
Han Cheng, Mengyu Liang, Yiwen Gao, et al.
Genes (2025) Vol. 16, Iss. 3, pp. 244-244
Open Access
Precise CAR-T-cell Therapy Targeting Non-Cancerous Diseases: Advances in Precision Medicine and Bioengineering
Chaojie Zhu, Fangzhou Wang, Zesheng Cheng, et al.
Precision medicine and engineering. (2025), pp. 100024-100024
Open Access
Chaojie Zhu, Fangzhou Wang, Zesheng Cheng, et al.
Precision medicine and engineering. (2025), pp. 100024-100024
Open Access
ETS-1 in tumor immunology: implications for novel anti-cancer strategies
Siyu Wang, Lei Wan, Xiao-Jun Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Siyu Wang, Lei Wan, Xiao-Jun Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Progress and challenges in developing allogeneic cell therapies
T. Deuse, Sonja Schrepfer
Cell stem cell (2025) Vol. 32, Iss. 4, pp. 513-528
Open Access
T. Deuse, Sonja Schrepfer
Cell stem cell (2025) Vol. 32, Iss. 4, pp. 513-528
Open Access
New horizons at the interface of artificial intelligence and translational cancer research
Josephine Yates, Eliezer M. Van Allen
Cancer Cell (2025) Vol. 43, Iss. 4, pp. 708-727
Closed Access
Josephine Yates, Eliezer M. Van Allen
Cancer Cell (2025) Vol. 43, Iss. 4, pp. 708-727
Closed Access
Depletion of CD8+ CAR T-cells leads to superior anti-tumor efficacy of pure CD4+ CAR T-cells against Acute Leukemias
Tim Sauer, Qian Chen, Hao Yao, et al.
Research Square (Research Square) (2025)
Closed Access
Tim Sauer, Qian Chen, Hao Yao, et al.
Research Square (Research Square) (2025)
Closed Access
Dextran-based T-cell expansion nanoparticles for manufacturing CAR T cells with augmented efficacy
Tao Zheng, Keerthana Ramanathan, Maria Ormhøj, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Tao Zheng, Keerthana Ramanathan, Maria Ormhøj, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
IL-4 exerts beneficial anti-tumor effect dependent on a short-range manner
Jingdi Zhang, Xianli Xue, Yufeng Zhang, et al.
Cytokine (2025) Vol. 191, pp. 156950-156950
Closed Access
Jingdi Zhang, Xianli Xue, Yufeng Zhang, et al.
Cytokine (2025) Vol. 191, pp. 156950-156950
Closed Access
The Potential Use of Digital Twin Technology for Advancing CAR-T Cell Therapy
Sara Sadat Aghamiri, Rada Amin
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 5, pp. 321-321
Open Access
Sara Sadat Aghamiri, Rada Amin
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 5, pp. 321-321
Open Access
New insights on potency assays from recent advances and discoveries in CAR T-cell therapy
Lipei Shao, Yanyan Zheng, Robert Somerville, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Lipei Shao, Yanyan Zheng, Robert Somerville, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
PP1A Modulates the Efficacy of Lenvatinib Plus ICIs Therapy by Inhibiting Ferroptosis in Hepatocellular Carcinoma
J. Zhou, Meng Gao, Shikun Zhang, et al.
Advanced Science (2025)
Open Access
J. Zhou, Meng Gao, Shikun Zhang, et al.
Advanced Science (2025)
Open Access
Dupilumab-associated lymphoproliferative disorders: a comprehensive review on clinicohistopathologic features and underlying mechanisms
Mingjia Li, Wei Zhao, Pan Lai, et al.
Current Opinion in Immunology (2025) Vol. 94, pp. 102563-102563
Closed Access
Mingjia Li, Wei Zhao, Pan Lai, et al.
Current Opinion in Immunology (2025) Vol. 94, pp. 102563-102563
Closed Access
Interleukin-4 modulates type I interferon to augment antitumor immunity
Hannah V. Newnes, Jesse D. Armitage, Anthony Buzzai, et al.
Science Advances (2025) Vol. 11, Iss. 20
Closed Access
Hannah V. Newnes, Jesse D. Armitage, Anthony Buzzai, et al.
Science Advances (2025) Vol. 11, Iss. 20
Closed Access
A new paradigm for cancer immunotherapy: Orchestrating type 1 and type 2 immunity for curative response
Bing Feng, Li Tang
Clinical and Translational Medicine (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Bing Feng, Li Tang
Clinical and Translational Medicine (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Vgamma1+ gammadelta T cell-derived IL-4 initiates CD8 T cell immunity
Shirley Le, Declan G. Murphy, Shangyi Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Shirley Le, Declan G. Murphy, Shangyi Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A preclinical study of allogeneic CD19 chimeric antigen receptor double‐negative T cells as an off‐the‐shelf immunotherapy drug against B‐cell malignancies
Dan Wang, Liuyang Wang, Shuai Liu, et al.
Clinical & Translational Immunology (2024) Vol. 13, Iss. 12
Open Access
Dan Wang, Liuyang Wang, Shuai Liu, et al.
Clinical & Translational Immunology (2024) Vol. 13, Iss. 12
Open Access
Harnessing Type II Cytokines to Reinvigorate Exhausted T Cells for Durable Cancer Immunotherapy
Wenle Zhang, Y. G. Wang, Bin Li
Genomics Proteomics & Bioinformatics (2024)
Open Access
Wenle Zhang, Y. G. Wang, Bin Li
Genomics Proteomics & Bioinformatics (2024)
Open Access
